© 2025 Actimo Labs Pty Ltd. All rights reserved.
Together we unlock insights, uncover potential, and drive breakthroughs because great models start with great data.
Partnering with Actimo Labs means gaining access to AI-powered precision results, through machine learning models trained on expertly curated antibody-antigen complexes, enabling fast and reliable epitope predictions.
Our platform helps de-risk R&D by identifying potential liabilities and redundancies early before costly wet-lab confirmations. With significant time and cost savings, you can avoid unnecessary rounds of screening and structural validation.
We believe that the pre-clinical development process is costly and time-consuming, and we see the potential for digital technologies to redefine this space, and we want to become leaders.
Our edge is in our team. We are builders, scientists, and engineers with experience working in computational biology and software development. Our experiences define our willingness to challenge the status quo.